Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

In this video, Colin Furze explores the concept of a secret tunnel and showcases various elements related to the construction ...

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...

Pirtobrutinib shows promising results in treating CLL, outperforming ibrutinib in a pivotal phase 3 trial, paving the way for ...

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and ...

July was a roller coaster for New York City FC. In Major League Soccer, the team won two road games while going 3-1-1, ...

Looking for value in crypto without breaking the bank? This guide dives into BlockDAG, Ethena, Hedera, and Stellar, which are ...

Owing to Briumvi's solid launch, TG's balance sheet is in excellent condition. Despite new competition, Briumvi's five-year ...

Lancaster is hosting an open house Wednesday, July 30, to gather public opinions on converting nine city streets from one-way ...

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Humanitarian aid organizations and international bodies have warned that Gaza is facing "critical" levels of hunger and that ...

This opportunity has now been extended through December 31, 2025, with $713,405 remaining thanks to an individual gift match ...